The SEC has expressed its intent to respond proactively to the impact of the coronavirus on capital markets and investors. Risks to investors can become heightened during a market downtur...
Our UK Corporate Finance Update: Coronavirus (COVID-19) – Related Measures and Guidance published earlier this week provided a summary of the initial measures taken, and guidance issued...
This memorandum highlights some annual general meeting (AGM) considerations for UK foreign private issuers (FPIs) with listings in the United States arising from coronavirus (COVID-19), i...
The coronavirus (COVID-19) emergency has led to the debt of many companies in private equity portfolios trading at a significant discount. As a result, an increasing number of private equ...
With the onset of the coronavirus (COVID-19) pandemic, this memorandum provides a brief summary of the first of what will likely be multiple rounds of measures taken, and guidance issued,...
Extreme dislocation and a major sell-off in global equity markets have led to many public companies finding their stock prices at severely depressed levels, often over 50% off last twelve...
On March 18, 2020, Congress passed the Families First Coronavirus Response Act (“FFCRA”), a sweeping legislative bill to address the growing concerns surrounding the novel coronavirus...
The coronavirus (COVID-19) is having enormous impact on all of us globally. We have been getting a broad array of questions about funding options and liquidity risk management. Our alert ...
Now is the season when many public companies are planning for and getting ready to finalize, print and mail a proxy statement for the annual meeting. What if, unfortunately, a company nee...
It is obvious that the risks presented by the novel coronavirus (COVID-19) transcend “business as usual” for market participants. How should Boards be approaching the risks and opport...